ACHE and early-onset autosomal dominant Alzheimer disease: According to cholinergic neurotransmission, acetylcholinesterase (AChE) inhibition would increase the levels of acetylcholine in the brain, thus improving cholinergic synapses in Alzheimer’s disease (AD) patients [3,4,5,6].